Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Large pharma companies spell out reasons why tariffs will harm US investments

2 days ago

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

2 days ago

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

2 days ago

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

3 days ago

FDA rejects Savara’s rare lung disease drug over limited manufacturing data

4 days ago

US warns drugmakers against misrepresenting cost of imported products

Last week

FDA names acting head of inspections; J&J again advocates for tax policies as alternative to tariffs

Last week

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

Last week

Samsung Biologics to separate manufacturing and biosimilar businesses

Last week

FDA announces efforts to facilitate drug importation from Canada

Last week

Mark Cuban compounder joins Trump's new manufacturing initiative

3 weeks ago

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

3 weeks ago

AGC Bio secures lentiviral contract; Thermo Fisher to make Cybin asset

3 weeks ago

Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate

3 weeks ago

Sanofi touts $20B investment in US over five years

3 weeks ago

Some generics, biosimilar drugmakers say they can withstand tariff impact

3 weeks ago

Roche could rethink $50B US expansion plan if new policies 'harm' operations

3 weeks ago

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

4 weeks ago

Lonza says its US-based sites are in high demand as pharma tariffs near

4 weeks ago

Bristol Myers' $40B US investment; Shionogi to buy Japanese drugmaker

4 weeks ago

Gilead reveals plans to put another $11B into US manufacturing

4 weeks ago

Teva plans staff cuts as it commits to accelerating growth

4 weeks ago

PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments

4 weeks ago

Charles River launches ‘strategic review’ alongside activist investor Elliott

4 weeks ago

12 3 4 Next page Last page